Federal investigators have launched a criminal investigation into Alere’s billing practices, focusing specifically on drug tests provided through the company’s toxicology unit, according to the Wall ...
Alere IncALR recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test, a unified solution of rapid and accurate diagnosis of RSV diseases. Notably, ...
WALTHAM, Mass., April 2, 2015 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food ...
When Alere ($ALR) CEO Namal Nawana took the reins of the company last year, he pledged he would get things back on track with a series of cost-cutting measures and by ...
When Alere ($ALR) CEO Namal Nawana stepped in a year ago, he pledged he would get the struggling company back on track by shedding noncore businesses, cutting costs ...
The president of the Michigan Medical Marijuana Association is concerned the saliva tests being used by police in a new roadside drug testing pilot program may have a ...
The FDA grants 510(k) clearance for Alere (NYSE:ALR-OLD)(ABT) unit Immunalysis' SEFRIA Fentanyl Urine Enzyme Immunoassay, the first regulatory approval for SEFRIA and the first 510(k)-cleared fentanyl ...
Abbott Labs acquires large Alere patent portfolio in $5.8 billion deal, increasing diagnostic lineup
Abbott Laboratories (NYSE:ABT) of Chicago, IL, is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. (NYSE:ALR) of Waltham, MA, in a $5.8 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback